Skip to main content
Top
Published in: Abdominal Radiology 4/2013

01-08-2013

Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI

Authors: Melanie Bruegel, Daniela Muenzel, Simone Waldt, Katja Specht, Ernst J. Rummeny

Published in: Abdominal Radiology | Issue 4/2013

Login to get access

Abstract

Objective

Primary hepatic angiosarcoma is a very rare and aggressive malignancy of vascular origin. We describe cross-sectional imaging findings of this entity with emphasis on dynamic contrast-enhanced (DCE) and diffusion-weighted (DWI) MR imaging.

Methods

Seven cases of pathologically confirmed hepatic angiosarcoma were retrospectively reviewed (CT and MRI examinations were available in seven and six patients, respectively). Two radiologists evaluated lesion growth patterns, attenuation, signal intensity characteristics, contrast enhancement patterns, and apparent diffusion coefficients (ADCs).

Results

Multifocal hepatic disease was present in six patients by means of a mixed pattern of large dominant masses and multiple small nodules; one patient had a solitary large mass. Unenhanced images depicted hemorrhagic areas and a markedly heterogeneous internal architecture within large tumors. Contrast-enhanced early phase images showed variable patterns including patchy peripheral or bizarre shaped intralesional foci of enhancement, peripheral rim enhancement, and small lesions without enhancement. On DCE images, the majority of lesions presented with varying degrees of progressive enhancement. Small nodules frequently displayed homogeneous enhancement on delayed phase images due to complete fill-in. DWI revealed a high interlesional variability of ADC values (range 0.57–2.41 × 10−3 mm2/s, mean 1.37 × 10−3 mm2/s).

Conclusion

Cross-sectional imaging findings of hepatic angiosarcoma reflect the varied histopathological composition of the tumors. Multifocal disease, hemorrhage within large lesions, as well as progressive enhancement on DCE images are typical features of hepatic angiosarcoma. The mean ADC of lesions was found to be slightly elevated in comparison with other hepatic malignancies.
Literature
1.
go back to reference Alrenga DP (1975) Primary angiosarcoma of the liver: review article. Int Surg 60:198–203PubMed Alrenga DP (1975) Primary angiosarcoma of the liver: review article. Int Surg 60:198–203PubMed
2.
go back to reference Falk H, Herbert J, Crowley S, et al. (1981) Epidemiology of hepatic angiosarcoma in the United States: 1964–1974. Environ Health Perspect 41:107–113PubMedCrossRef Falk H, Herbert J, Crowley S, et al. (1981) Epidemiology of hepatic angiosarcoma in the United States: 1964–1974. Environ Health Perspect 41:107–113PubMedCrossRef
3.
go back to reference Locker GY, Doroshow JH, Zwelling LA, Chabner BA (1979) The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 58:48–64CrossRef Locker GY, Doroshow JH, Zwelling LA, Chabner BA (1979) The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 58:48–64CrossRef
5.
go back to reference Drinkovic I, Brkljacic B (1996) Two cases of lethal complications following ultrasound-guided percutaneous fine-needle biopsy of the liver. Cardiovasc Intervent Radiol 19:360–363. doi:10.1007/BF02570192 PubMedCrossRef Drinkovic I, Brkljacic B (1996) Two cases of lethal complications following ultrasound-guided percutaneous fine-needle biopsy of the liver. Cardiovasc Intervent Radiol 19:360–363. doi:10.​1007/​BF02570192 PubMedCrossRef
6.
go back to reference Mahony B, Jeffrey RB, Federle MP (1982) Spontaneous rupture of hepatic and splenic angiosarcoma demonstrated by CT. AJR Am J Roentgenol 138:965–966PubMedCrossRef Mahony B, Jeffrey RB, Federle MP (1982) Spontaneous rupture of hepatic and splenic angiosarcoma demonstrated by CT. AJR Am J Roentgenol 138:965–966PubMedCrossRef
10.
go back to reference Buetow PC, Buck JL, Ros PR, Goodman ZD (1994) Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiographics 14:153–166PubMed Buetow PC, Buck JL, Ros PR, Goodman ZD (1994) Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiographics 14:153–166PubMed
11.
go back to reference Bruegel M, Holzapfel K, Gaa J, et al. (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485. doi:10.1007/s00330-007-0785-9 PubMedCrossRef Bruegel M, Holzapfel K, Gaa J, et al. (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485. doi:10.​1007/​s00330-007-0785-9 PubMedCrossRef
13.
go back to reference Fracanzani AL, Conte D, Fraquelli M, et al. (2001) Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 33:647–651. doi:10.1053/jhep.2001.22506 PubMedCrossRef Fracanzani AL, Conte D, Fraquelli M, et al. (2001) Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 33:647–651. doi:10.​1053/​jhep.​2001.​22506 PubMedCrossRef
14.
go back to reference Levy DW, Rindsberg S, Friedman AC, et al. (1986) Thorotrast-induced hepatosplenic neoplasia: CT identification. AJR Am J Roentgenol 146:997–1004PubMedCrossRef Levy DW, Rindsberg S, Friedman AC, et al. (1986) Thorotrast-induced hepatosplenic neoplasia: CT identification. AJR Am J Roentgenol 146:997–1004PubMedCrossRef
17.
go back to reference Peterson MS, Baron RL, Rankin SC (2000) Hepatic angiosarcoma: findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol 175:165–170PubMedCrossRef Peterson MS, Baron RL, Rankin SC (2000) Hepatic angiosarcoma: findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol 175:165–170PubMedCrossRef
18.
go back to reference Silverman PM, Ram PC, Korobkin M (1983) CT appearance of abdominal thorotrast deposition and thorotrast-induced angiosarcoma of the liver. J Comput Assist Tomogr 7:655–658PubMedCrossRef Silverman PM, Ram PC, Korobkin M (1983) CT appearance of abdominal thorotrast deposition and thorotrast-induced angiosarcoma of the liver. J Comput Assist Tomogr 7:655–658PubMedCrossRef
19.
go back to reference White PG, Adams H, Smith PM (1993) The computed tomographic appearances of angiosarcoma of the liver. Clin Radiol 48:321–325PubMedCrossRef White PG, Adams H, Smith PM (1993) The computed tomographic appearances of angiosarcoma of the liver. Clin Radiol 48:321–325PubMedCrossRef
20.
go back to reference Worawattanakul S, Semelka RC, Kelekis NL, Woosley JT (1997) Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy. Magn Reson Imaging 15:613–617PubMedCrossRef Worawattanakul S, Semelka RC, Kelekis NL, Woosley JT (1997) Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy. Magn Reson Imaging 15:613–617PubMedCrossRef
Metadata
Title
Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI
Authors
Melanie Bruegel
Daniela Muenzel
Simone Waldt
Katja Specht
Ernst J. Rummeny
Publication date
01-08-2013
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9967-2

Other articles of this Issue 4/2013

Abdominal Radiology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.